CLINICAL_TRIALS
trial_result
· 2015-08-21
Clinical Trial Update: A Phase 1 Study of XL019 in Adults With Polycythemia Vera [Phase 1]
Summary
The Phase 1 study XL019 in adults with Polycythemia Vera has been terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Exelixis | Conditions: Polycythemia Vera | Phase 1 | Status: TERMINATED